[Therapy of intravascular coagulation].
D000925:Anticoagulants / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001831:Body Temperature; D002648:Child; D003911:Dextrans / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000628:therapy*; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000627:therapeutic use; D010958:Plasminogen / Q000627:therapeutic use; D010973:Platelet Adhesiveness; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D012769:Shock / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D014884:Waterhouse-Friderichsen Syndrome / Q000188:drug therapy
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003911:Dextrans; D010952:Plasma Substitutes; D010958:Plasminogen; D006493:Heparin; D013300:Streptokinase
Therapie der intravasalen Gerinnung